In addition, higher expression of 12-HEDH/PTGR1, an enzyme that degrades LTB4, as well as prostaglandins, may be associated with worse prognoses for GBM patients [121], although GEPIA did not confirm such a link [9]. The gene discussed is PTGR1; the disease is glioblastoma.